Wall Street Analysts See a 229.34% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?

Nuvectis Pharma, Inc. (NVCT) closed the last trading session at $6.68, gaining 2.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 22 indicates a 229.3% upside potential. The mean estimate comprises three short-term price targets with a standard deviation of $2.65. While the lowest estimate of$ 20 indicates a 199.4% increase from the current price level, the most optimistic analy ...